MATERIAL SAFETY DATA SHEET
SECTION 1 - IDENTIFICATION OF PRODUCT AND COMPANY
1-866-531-8896
Pfizer Inc Emergency telephone
24 Hours
Pfizer Animal Health Hours of operation
1-800-366-5288
235 East 42nd Street Telephone
New York, NY 10017
Trade names RespiSure庐; RespiSure-ONE鈩?
Mycoplasma Hyopneumoniae Bacterin
Product name
Veterinary Vaccine
Therapeutic use
Milky, white liquid in vial
Description
SECTION 2 - COMPOSITION
Ingredient CAS Number Amount
Amphigen base Not assigned Proprietary
EDTA solution Not assigned Proprietary
Merthiolate (as mercury)* 54-64-8 Trace
Mycoplasma Hyopneumoniae Not assigned Proprietary
Polysorbate 80 - NF 9005-65-6 Proprietary
Sorbitan oleate* 1338-43-8 <5%
White mineral oil, NF* 8042-47-5 Proprietary
*Hazardous
Note: Ingredient(s) indicated as hazardous have been assessed under standards
for workplace safety.
SECTION 3 - HAZARDS IDENTIFICATION
Signal word CAUTION!
Statements of hazard MAY CAUSE RESPIRATORY TRACT IRRITATION
May cause eye irritation.
Eye effects
May cause allergic reaction.
Skin effects
Exposure to high concentrations of vapor or mist may cause minor
Inhalation effects
respiratory irritation. An Occupational Exposure Limit has been
established for one or more of the ingredients (see Section 8).
May cause lung damage if swallowed. Vomiting of petroleum-containing
Ingestion effects
liquids can result in chemical pneumonitis.
0104B - Mycoplasma Hyopneumoniae Bacterin Pfizer Inc.
Revision date: 08/13/03, Version: 1.4.0 Page 1 of 6
SECTION 3 - HAZARDS IDENTIFICATION ... continued
Other potential health In the event of accidental injection, an allergic reaction may occur. If an
effects allergic reaction occurs, the worker should be removed to the nearest
emergency room and the appropriate therapy instituted.
accidental injection
Route of entry
This document has been prepared in accordance with standards for
NOTE:
workplace safety, which require the inclusion of all known hazards of the
product or its ingredients regardless of the potential risk. The
precautionary statements and warnings included may not apply in all
cases. Your needs may vary depending upon the potential for exposure in
your workplace.
SECTION 4 - FIRST AID MEASURES
Skin Wash skin with soap and water. If irritation occurs or persists, get medical
attention.
Eyes Immediately flush eyes with water for at least 15 minutes. If irritation
occurs or persists, get medical attention.
Inhalation Remove to fresh air. If not breathing, give artificial respiration. Get
medical attention immediately.
In the event of swallowing this material, seek medical assistance. DO NOT
Ingestion
INDUCE VOMITING. Never give anything by mouth to an unconscious
person.
This product contains petroleum distillate, aspiration into the lungs can
Note to physician
result in pulmonary edema.
SECTION 5 - FIRE FIGHTING MEASURES
This product is a nonflammable aqueous solution.
General hazard
Dike and collect water used to fight fire.
Fire fighting instructions
As for primary cause of fire.
Extinguishing media
Non-flammable
Flash point
Toxic and corrosive gases including carbon monoxide and oxides of
Hazardous combustion
nitrogen may be generated.
products
SECTION 6 - ACCIDENTAL RELEASE MEASURES
Review Sections 3, 8 and 12 before proceeding with clean up.
General
0104B - Mycoplasma Hyopneumoniae Bacterin Pfizer Inc.
Revision date: 08/13/03, Version: 1.4.0 Page 2 of 6
SECTION 6 - ACCIDENTAL RELEASE MEASURES ... continued
Small spill Contain the source of the spill or leak. Use non-combustible absorbent
material to wipe up spill and place in a sealed container for disposal.
Large spill Contain the source of the spill or leak if it is safe to do so. Use appropriate
containment to avoid environmental contamination. Dike, pump, or use non-
combustible material to absorb spill; then place in a labeled container for
disposal. Close container and move it to a secure holding area. Prevent
runoff from entering drains, sewers, or streams.
SECTION 7 - HANDLING AND STORAGE
General handling Use with adequate ventilation. Avoid contact with eyes, skin and clothing.
Avoid breathing vapor or mist. Use appropriate personal protective
equipment.
Follow package instructions
Storage conditions
2-7掳C. Do not freeze.
Temperature range
for storage
SECTION 8 - EXPOSURE CONTROLS/PERSONAL PROTECTION
Exposure limits
Compound Issuer Type OEL
Merthiolate (as mercury) OSHA TWA-8 Hr 0.01 mg/m鲁 (skin)
ACGIH TWA-8 Hr 0.1 mg/m鲁 (skin)
White mineral oil, NF OSHA TWA-8 HR 5 mg/m鲁 (Oil Mist, mineral)
Good general ventilation should be sufficient to control airborne levels.
Ventilation
In the event of a spill where the applicable Occupational Exposure Limit
Respiratory protection
(OEL) may be exceeded, wear an appropriate respirator with a protection
factor sufficient to control exposures below the OEL.
Eye protection Not required under normal conditions of use. Wear eye protection if eye
contact is possible.
None required for the normal use of this material. Wash hands and arms
Skin protection
thoroughly after handling this material. Clean up spills immediately.
Hand protection Not required for the normal use of this product. Wear impervious gloves if
skin contact is possible.
SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES
Liquid
Physical form
White
Color
0104B - Mycoplasma Hyopneumoniae Bacterin Pfizer Inc.
Revision date: 08/13/03, Version: 1.4.0 Page 3 of 6
SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ... continued
Milky
Clarity
Mixture
Molecular weight
Mixture
Molecular formula
7.0 +/- 1.5 standard pH units
pH
>100掳C
Boiling point
Not applicable
Melting point
No data available
Density
No data available
Vapor pressure
Components are soluble in water
Water solubility
No data available
Solvent solubility
1.0 +/-0.2
Specific gravity
SECTION 10 - STABILITY AND REACTIVITY
Stable
Reactivity
Avoid extreme temperatures
Conditions to avoid
Oxidizers
Incompatibilities
None known
Hazardous
decomposition
products
Will not occur
Hazardous
polymerization
SECTION 11 - TOXICOLOGY INFORMATION
The antigens included in this product are non-infectious. All have been
Toxicology summary
prepared from killed or inactivated preparations of microorganisms.
Acute toxicity
Compound Type Route Species Result
Polysorbate 80 - NF LD50 Oral Rat 25,000 mg/kg
Eye Not determined for this mixture. Oil vapors or mist may cause eye
irritation.
Not determined for this mixture. No skin irritation expected based on
Skin
individual components.
0104B - Mycoplasma Hyopneumoniae Bacterin Pfizer Inc.
Revision date: 08/13/03, Version: 1.4.0 Page 4 of 6
SECTION 11 - TOXICOLOGY INFORMATION ... continued
Not determined for this mixture. Oil vapors or mists may cause
Inhalation
respiratory tract and mucous membrane irritation
May cause lung damage if swallowed. Vomiting of petroleum-containing
Ingestion
liquids can result in chemical pneumonitis.
This product contains merthiolate which is considered to be a skin
Sensitization
sensitizer.
High doses of sorbitan oleate fed to rats for 16 weeks resulted in kidney
Subchronic effects
and liver effects.
No data available
Chronic effects/
carcinogenicity
None of the components of this formulation are listed as a carcinogen by
Carcinogen status
IARC, NTP or OSHA.
SECTION 12 - ECOLOGICAL INFORMATION
The environmental characteristics of this material have not been fully
Environmental overview
evaluated. This product contains trace quantities of mercury, releases to
the environment should be avoided.
SECTION 13 - DISPOSAL INFORMATION
Incineration is the recommended method of disposal for this material.
Disposal procedure
Observe all local and national regulations when disposing of this mixture.
This product contains trace quantities of mercury and may qualify as a
RCRA Hazardous Waste. Status should be confirmed using the EPA
Toxicity Characteristic Leaching Procedure (TCLP).
SECTION 14 - TRANSPORTATION INFORMATION
Not regulated for transport under USDOT, EUADR, IATA, or IMDG
General shipping
regulations.
instructions
SECTION 15 - REGULATORY INFORMATION
Not classified
EU Classification
This product has been classified in accordance with the hazard criteria of
Canadian WHMIS
the CPR and the MSDS contains all of the information required by the
CPR.
0104B - Mycoplasma Hyopneumoniae Bacterin Pfizer Inc.
Revision date: 08/13/03, Version: 1.4.0 Page 5 of 6
SECTION 16 - OTHER
Disclaimer Pfizer Inc believes that the information contained in this Material
Safety Data Sheet is accurate. While Pfizer provides this information
in good faith, it does not expressly or impliedly warrant its accuracy.
0104B - Mycoplasma Hyopneumoniae Bacterin Pfizer Inc.
Revision date: 08/13/03, Version: 1.4.0 Page 6 of 6
|